Top Markets
#1 Black Phoenix Black Phoenix +21,404.60%
#2 Nesa Nesa +696.88%
#3 Kinesis Silver Kinesis Silver +55.34%
#4 Ontology Gas Ontology Gas +28.45%
#5 BNB Attestation Service BNB Attestation Service +23.44%
#6 QuantixAI QuantixAI +23.07%
#7 EXOD EXOD +22.78%
#8 Biconomy Biconomy +19.06%
#9 Magma Finance Magma Finance +18.07%
#10 Derive Derive +16.29%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Rank in Stocks #3923
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Share Price
$89.96
Market Cap
$4.45B
Change (1 day)
-0.16%
Change (1 year)
-14.59%
Country
IT
Trade DiaSorin S.p.A. (DIA)

Category

Healthcare
Revenue for DiaSorin S.p.A. (DIA)
Revenue in Aug 2026 TTM: 0
According to DiaSorin S.p.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DiaSorin S.p.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 $7.23B -
US